{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T13:46:28Z","timestamp":1768484788967,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["72180466"],"award-info":[{"award-number":["72180466"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.dmpk.2023.100491","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T20:48:41Z","timestamp":1674506921000},"page":"100491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Novel food drug interaction mechanism involving acyclovir, chitosan and endogenous mucus"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5618-3318","authenticated-orcid":false,"given":"Mauricio A.","family":"Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6n\u00fcl","family":"Hensler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jozef","family":"Al-Gousous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Pielenhofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Lennern\u00e4s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Langguth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmpk.2023.100491_bib1","series-title":"Advances in food and nutrition research","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/B978-0-12-416003-3.00007-X","article-title":"Chitosan as potential marine nutraceutical","author":"Je","year":"2012"},{"issue":"7","key":"10.1016\/j.dmpk.2023.100491_bib2","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1023\/A:1012160102740","article-title":"Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement","volume":"14","author":"Schipper","year":"1997","journal-title":"Pharm Res (N Y)"},{"issue":"7","key":"10.1016\/j.dmpk.2023.100491_bib3","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1002\/jps.23170","article-title":"Vivo application of chitosan to facilitate intestinal acyclovir absorption in rats","volume":"101","author":"Masuda","year":"2012","journal-title":"J\u00a0Pharm Sci"},{"issue":"9","key":"10.1016\/j.dmpk.2023.100491_bib4","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1080\/03639040902774156","article-title":"Effect of chitosan glutamate, carbomer 974P, and EDTA on the in\u00a0vitro Caco-2 permeability and oral pharmacokinetic profile of acyclovir in rats Effect of intestinal enhancer on acyclovir absorption","volume":"35","author":"Merzlikine","year":"2009","journal-title":"Drug Dev Ind Pharm"},{"issue":"6","key":"10.1016\/j.dmpk.2023.100491_bib5","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/jphp.12551","article-title":"Effect of permeability enhancers on paracellular permeability of acyclovir","volume":"68","author":"Ates","year":"2016","journal-title":"J\u00a0Pharm Pharmacol"},{"issue":"3","key":"10.1016\/j.dmpk.2023.100491_bib6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/03639040701655952","article-title":"In\u00a0vitro assessment of acyclovir permeation across cell monolayers in the presence of absorption enhancers","volume":"34","author":"Shah","year":"2008","journal-title":"Drug Dev Ind Pharm"},{"issue":"12","key":"10.1016\/j.dmpk.2023.100491_bib7","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1021\/acs.molpharmaceut.7b00353","article-title":"Preclinical effect of absorption modifying excipients on rat intestinal transport of model compounds and the mucosal barrier marker 51Cr-edta","volume":"14","author":"Dahlgren","year":"2017","journal-title":"Mol Pharm"},{"issue":"1\u20132","key":"10.1016\/j.dmpk.2023.100491_bib8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijpharm.2018.05.029","article-title":"The effects of three absorption-modifying critical excipients on the in\u00a0vivo intestinal absorption of six model compounds in rats and dogs","volume":"547","author":"Dahlgren","year":"2018","journal-title":"Int J Pharm [Internet]"},{"issue":"7","key":"10.1016\/j.dmpk.2023.100491_bib9","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1007\/s11095-014-1613-y","article-title":"The influence of chitosan on the oral bioavailability of acyclovir - a comparative bioavailability study in humans","volume":"32","author":"Kubbinga","year":"2015","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.dmpk.2023.100491_bib10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejpb.2019.01.021","article-title":"The effect of chitosan on the bioaccessibility and intestinal permeability of acyclovir","volume":"136","author":"Kubbinga","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"10.1016\/j.dmpk.2023.100491_bib11","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/bip.22372","article-title":"Particle tracking microrheology of purified gastrointestinal mucins","volume":"101","author":"Georgiades","year":"2014","journal-title":"Biopolymers"},{"issue":"11","key":"10.1016\/j.dmpk.2023.100491_bib12","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/mabi.201500158","article-title":"Probing the mucoadhesive interactions between porcine gastric mucin and some water-soluble polymers","volume":"15","author":"Albarkah","year":"2015","journal-title":"Macromol Biosci"},{"key":"10.1016\/j.dmpk.2023.100491_bib13","article-title":"Improved WATERGATE pulse sequences for solvent suppression in NMR spectroscopy cite this paper A simple scheme for t he design of solvent-suppression pulses improved WATERGATE pulse sequences for solvent suppression in NMR spectroscopy","volume":"132","author":"Nicholson","year":"1998","journal-title":"J\u00a0Magn Reson"},{"key":"10.1016\/j.dmpk.2023.100491_bib14","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ejpb.2015.01.014","article-title":"Steric and interactive barrier properties of intestinal mucus elucidated by particle diffusion and peptide permeation","volume":"95","author":"Boegh","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"10.1016\/j.dmpk.2023.100491_bib15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1128\/AAC.21.3.393","article-title":"Pharmacokinetics and tolerance of acyclovir, a new anti-herpesvirus agent, in humans","volume":"21","author":"Laskin","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.dmpk.2023.100491_bib16","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1021\/mp500210c","article-title":"Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state","volume":"11","author":"Mudie","year":"2014","journal-title":"Mol Pharm"},{"issue":"5","key":"10.1016\/j.dmpk.2023.100491_bib17","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1208\/s12248-016-9953-7","article-title":"A\u00a0quantitative review and meta-models of the variability and factors affecting oral drug absorption\u2014Part II: gastrointestinal transit time","volume":"18","author":"Abuhelwa","year":"2016","journal-title":"AAPS J"},{"issue":"7","key":"10.1016\/j.dmpk.2023.100491_bib18","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/bdd.1792","article-title":"Integrating drug permeability with dissolution profile to develop IVIVC","volume":"33","author":"Takano","year":"2012","journal-title":"Biopharm Drug Dispos"},{"issue":"4","key":"10.1016\/j.dmpk.2023.100491_bib19","first-page":"508","article-title":"Pharmacokinetics and bioavailability of different formulations of aciclovir","volume":"45","author":"Vergin","year":"1995","journal-title":"Arzneimittelforschung"},{"issue":"1","key":"10.1016\/j.dmpk.2023.100491_bib20","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.xphs.2021.10.013","article-title":"Predicting pharmacokinetics of multisource acyclovir oral products through physiologically based biopharmaceutics modeling","volume":"111","author":"Garc\u00eda","year":"2022","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.dmpk.2023.100491_bib21","series-title":"Vitro determination of routes of buccal transport","first-page":"1182","article-title":"Transbuccal delivery of acyclovir: I","volume":"15","author":"Shojaei","year":"1998"},{"issue":"3","key":"10.1016\/j.dmpk.2023.100491_bib22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/apt.16673","article-title":"Small bowel water content assessed by MRI in health and disease: a collation of single-centre studies","volume":"55","author":"Dellschaft","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.dmpk.2023.100491_bib23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/bdd.1798","article-title":"Mechanistic investigation of food effect on disintegration and dissolution of BCS class III compound solid formulations: the importance of viscosity","volume":"33","author":"Radwan","year":"2012","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.dmpk.2023.100491_bib24","first-page":"172","article-title":"Drug diffusion in biomimetic hydrogels: importance for drug transport and delivery in non-vascular tumor tissue","author":"Degerstedt","year":"2022","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.dmpk.2023.100491_bib25","series-title":"Pharmaceutical research","first-page":"543","article-title":"The interesting case of acyclovir delivered using chitosan in humans: is it a drug issue or formulation issue?","volume":"33","author":"Srinivas","year":"2016"},{"issue":"3","key":"10.1016\/j.dmpk.2023.100491_bib26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1023\/A:1015890516119","article-title":"Mechanism of acyclovir uptake in rat jejunum","volume":"7","author":"Meadows","year":"1990","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.dmpk.2023.100491_bib27","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jpba.2018.04.041","article-title":"Rheological analysis and mucoadhesion: a 30 year-old and still active combination","volume":"156","author":"Rossi","year":"2018","journal-title":"J\u00a0Pharm Biomed Anal [Internet"},{"issue":"10","key":"10.1016\/j.dmpk.2023.100491_bib28","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1023\/A:1015845031488","article-title":"Acyclovir permeation enhancement across intestinal and nasal mucosae by bile salt-acylcarnitine mixed micelles","volume":"9","author":"Park","year":"1992","journal-title":"Pharm Res (N Y)"},{"issue":"6","key":"10.1016\/j.dmpk.2023.100491_bib29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","article-title":"Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers","volume":"64","author":"Ensign","year":"2012","journal-title":"Adv Drug Deliv Rev [Internet]"},{"issue":"2","key":"10.1016\/j.dmpk.2023.100491_bib30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","article-title":"Barrier properties of mucus","volume":"61","author":"Cone","year":"2009","journal-title":"Adv Drug Deliv Rev [Internet]"},{"key":"10.1016\/j.dmpk.2023.100491_bib31","first-page":"624","article-title":"P-glycoprotein-mediated transport in a mucus-supplemented Caco-2 cell model in the presence of different surfactants","author":"Jakobsen","year":"2022","journal-title":"Int J Pharm"},{"issue":"8","key":"10.1016\/j.dmpk.2023.100491_bib32","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s11095-022-03312-z","article-title":"Lack of an effect of polysorbate 80 on intestinal drug permeability in humans","volume":"39","author":"Metry","year":"2022","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.dmpk.2023.100491_bib33","first-page":"497","volume":"14","author":"Lindahl","year":"1997"},{"key":"10.1016\/j.dmpk.2023.100491_bib34","volume":"52","author":"Ylitalo","year":"2002"},{"key":"10.1016\/j.dmpk.2023.100491_bib35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijpharm.2018.07.057","article-title":"Effect of absorption-modifying excipients, hypotonicity, and enteric neural activity in an in\u00a0vivo model for small intestinal transport","volume":"549","author":"Dahlgren","year":"2018","journal-title":"Int J Pharm"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436723000034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436723000034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:57:09Z","timestamp":1761163029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436723000034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":35,"alternative-id":["S1347436723000034"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2023.100491","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel food drug interaction mechanism involving acyclovir, chitosan and endogenous mucus","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2023.100491","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100491"}}